hydralazine has been researched along with Telangiectasis in 1 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Telangiectasis: Permanent dilation of preexisting blood vessels (CAPILLARIES; ARTERIOLES; VENULES) creating small focal red lesions, most commonly in the skin or mucous membranes. It is characterized by the prominence of skin blood vessels, such as vascular spiders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McWeeney, J | 1 |
| Finnegan, P | 1 |
1 other study available for hydralazine and Telangiectasis
| Article | Year |
|---|---|
Vasodilator therapy of pulmonary hypertension in the CRST syndrome.
Topics: Calcinosis; Female; Humans; Hydralazine; Hypertension, Pulmonary; Male; Middle Aged; Raynaud Disease | 1982 |